Epilepsi Tedavisinde Ketojenik Diyet Kullanımı

Yazarlar

Emine Tekin
https://orcid.org/0000-0002-5115-8890

Özet

Ketojenik diyet (KD), enerjinin büyük oranla keton cisimlerinden temin edildiği, yüksek yağ ile düşük protein ve karbonhidrat içeren özel bir diyet şeklidir. Klasik 4:1 yağ/protein+karbonhidrat oranının yanı sıra orta zincirli yağ asiti (MCT) diyeti, Modifiye MCT diyeti, düşük glisemik indeksli diyet ve Modifiye Atkins diyeti (MAD) gibi alternatif uygulamaları mevcuttur. İki antikonvülzif ilaca yanıt vermeyen dirençli epilepsilerde önerilen bu diyet, GLUT-1 eksikliği ve Piruvat Dehidrogenaz eksikliğinde ise ilk seçenek tedavidir. Etki mekanizmasında keton cisimlerinin kan-beyin bariyerini geçmesi, GABA seviyelerindeki artış, nöronal membran hiperpolarizasyonu ve mTOR yolağının inhibisyonu rol oynamaktadır. Tedavi öncesinde karnitin eksikliği, beta-oksidasyon defektleri ve porfiri gibi mutlak kontrendikasyonlar değerlendirilmelidir. Uygulama sürecinde gastrointestinal semptomlar, dislipidemi, hipoglisemi, büyüme geriliği ve böbrek taşı gibi yan etkiler görülebileceğinden nörolog, diyetisyen ve hemşireden oluşan uzman bir ekip tarafından hasta yakından izlenmelidir. Tedavinin etkinliğine karar verilebilmesi için en az üç ay sürdürülmesi, fayda sağlayan vakalarda iki yıl devam edilmesi ve diyetin tedricen kesilmesi gerekmektedir. 

Referanslar

Wilder RM. The effect of ketonemia on the course of epilepsy. Mayo Clin Bulletin 1921; 2:307.

Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007; 48:43-58.

Bough KJ, Wetherington J, Hassel B, et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 2006; 60:223-235.

Danial NN, Hartman AL, Stafstrom CE, Thio LL. How does the ketogenic diet work? Four potential mechanisms. J Child Neurol 2013; 28:1027-33.

Rudy L, Carmen R, Daniel R, Artemio R, Moisés RO. Anticonvulsant mechanisms of the ketogenic diet and caloric restriction. Epilepsy Res. 2020;168:106499. doi: 10.1016/j.eplepsyres.2020.106499.

Olson CA, Vuong HE, Yano JM, et al. The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet. Cell 2018; 173:1728-41

Calderón N, Betancourt L, Hernández L, Rada P. A ketogenic diet modifies glutamate, gamma aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study. Neurosci Lett. 2017; 642:158-62.

Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia 2001; 42:1255-60.

Kossoff EH, Zupec-Kania BA, Auvin S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 2018; 3:175-192.

Laux L, Blackford R. The ketogenic diet in Dravet syndrome. J Child Neurol. 2013;28:1041-4. doi: 10.1177/0883073813487599.

Kass HR, Winesett SP, Bessone SK, et al. Use of dietary therapies amongst patients with GLUT1 deficiency syndrome. Seizure 2016; 35:83-7.

Prezioso G, Carlone G, Zaccara G, Verrotti A. Efficacy of ketogenic diet for infantile spasms: A systematic review. Acta Neurol Scand 2018; 137:4-11.

Dressler A, Benninger F, Trimmel-Schwahofer P, et al. Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: A single-center parallel-cohort randomized controlled trial. Epilepsia 2019; 60:441-51.

Youn SE, Park S, Kim SH, Lee JS, Kim HD, Kang HC. Long-term outcomes of ketogenic diet in patients with tuberous sclerosis complex-derived epilepsy. Epilepsy Res. 2020;164:106348. doi: 10.1016/j.eplepsyres.2020.106348.

Park S, Lee EJ, Eom S, Kang HC, Lee JS, Kim HD. Ketogenic Diet for the Management of Epilepsy Associated with Tuberous Sclerosis Complex in Children. J Epilepsy Res. 2017;30:45-49. doi: 10.14581/jer.17008.

Kossoff EH, McGrogan JR, Freeman JM. Benefits of an all-liquid ketogenic diet. Epilepsia 2004; 45:1163.

Appavu B, Vanatta L, Condie J, Kerrigan JF, Jarrar R. Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure. 2016;41:62-5. doi: 10.1016/j.seizure.2016.07.006.

Henderson CB, Filloux FM, Alder SC, et al. Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol 2006; 21:193-8.

Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev 2016; 2:CD001903.

Guzel O, Uysal U, Arslan N. Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: A single center experience from Turkey. Eur J Paediatr Neurol. 2019;23:143-151. doi: 10.1016/j.ejpn.2018.11.007.

Neal EG, Chaffe H, Schwartz RH, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009; 50:1109-17.

Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 2013; 54:481-6.

Kossoff EH, Bosarge JL, Miranda MJ, et al. Will seizure control improve by switching from the modified Atkins diet to the traditional ketogenic diet? Epilepsia 2010; 51:2496-9.

Poorshiri B, Barzegar M, Tahmasebi S, et al. The efficacy comparison of classic ketogenic diet and modified Atkins diet in children with refractory epilepsy: a clinical trial. Acta Neurol Belg 2019. doi: 10.1007/s13760-019-01225-0. Online ahead of print.

Güzel O, Yılmaz U, Uysal U, Arslan N. The effect of olive oil-based ketogenic diet on serum lipid levels in epileptic children. Neurol Sci 2016; 37:465-70.

Özdemir R, Güzel O, Küçük M, Karadeniz C, Katipoglu N, Yılmaz Ü, Yılmazer MM, Meşe T. The Effect of the Ketogenic Diet on the Vascular Structure and Functions in Children With Intractable Epilepsy. Pediatr Neurol. 2016;56:30-34. doi: 10.1016/j.pediatrneurol.2015.10.017.

Ozdemir R, Kucuk M, Guzel O, Karadeniz C, Yilmaz U, Mese T. Does ketogenic diet have any negative effect on cardiac systolic and diastolic functions in children with intractable epilepsy?: One-year follow-up results. Brain Dev. 2016;38:842-7. doi: 10.1016/j.braindev.2016.03.009.

Bergqvist AG, Schall JI, Gallagher PR, et al. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia 2005; 46:1810-9.

Lin A, Turner Z, Doerrer SC, et al. Complications During Ketogenic Diet Initiation: Prevalence, Treatment, and Influence on Seizure Outcomes. Pediatr Neurol 2017; 68:35-9.

Arslan N, Kose E, Guzel O. The Effect of Ketogenic Diet on Serum Selenium Levels in Patients with Intractable Epilepsy. Biol Trace Elem Res 2017; 178:1-6.

Kossoff EH, Pyzik PL, Furth SL, et al. Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002; 43:1168-71.

Coppola G, Epifanio G, Auricchio G, et al. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Brain Dev 2006; 28:358-65.

Stevens CE, Turner Z, Kossoff EH. Hepatic Dysfunction as a Complication of Combined Valproate and Ketogenic Diet. Pediatr Neurol 2016; 54:82-4.

Martinez CC, Pyzik PL, Kossoff EH. Discontinuing the ketogenic diet in seizure-free children: recurrence and risk factors. Epilepsia 2007; 48:187-90.

Kossoff EH, Turner Z, Bergey GK. Home-guided use of the ketogenic diet in a patient for more than 20 years. Pediatr Neurol 2007; 36:424-5.

Worden LT, Turner Z, Pyzik PL, et al. Is there an ideal way to discontinue the ketogenic diet? Epilepsy Res 2011; 95:232-6.

Tekin E, Serdaroğlu FM, Şahin Ş, Taşdemir HA. Ketogenic diet experience at Ondokuz Mayıs University. Neurol Sci. 2020 Oct 26. doi: 10.1007/s10072-020-04853-0. Epub ahead of print. PMID: 33104909.

Gelecek

17 Mayıs 2021

Lisans

Lisans